Height-related risk factors for prostate cancer

British Journal of Cancer

Volumn 82, Issue 1, 2000, Pages 241-245

  Norrish, A E ^a   McRae, C U ^b   Holdaway, I M ^b   Jackson, R T ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

Familial; Growth; Height; IGF 1; Prostate neoplasms

Indexed keywords

SOMATOMEDIN C;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BODY GROWTH; CANCER LOCALIZATION; CANCER RISK; CANCER STATISTICS; CONTROLLED STUDY; FAMILIAL CANCER; GROWTH HORMONE BLOOD LEVEL; HEIGHT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR GROWTH;

EID: 0033986994     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.1999.0906     Document Type: Article

References (24)

1. Andersson S-O, Baron J, Bergstrom R, Lindgren C, Wolk A and Adami H-O (1996) Lifestyle factors and prostate cancer risk: a case - control study in Sweden. Cancer Epidemiol Biomarkers Prev 5: 509 -513
2. Andersson S-O, Wolk A, Bergstrom R, Adami H-O, Engholm G, Englund A and Nyren O (1997) Body size and prostate cancer: a 20-year follow-up study among 135 006 Swedish construction workers. J Natl Cancer Inst 89: 385-389
3. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH and Pollak M (1998) Plasma insulin-like growth factor-1 and prostate cancer risk: a prospective study. Science 279: 563-566
4. Cohen P, Peehl DM, Lamson N and Rosenfield RG (1991) Insulin-like growth factors (IGFs), IGF receptors and IGF binding proteins in primary cultures of prostate epithelial cells. J Clin Endocrinol Metab 73: 401-407
5. Cohen P, Peehl DM, Graves HCB and Rosenfield RG (1994) Biological effects of prostate specific antigen (PSA) as an IGF binding protein-3 (IGFBP-3) protease. J Endocrinol 142: 407-415
6. Ekbom A, Hsieh CC, Lipworth L, Wolk A, Ponten J, Adami H-O and Trichopoulos D (1996) Perinatal characteristics in relation to incidence of and mortality from prostate cancer. Br Med J 313: 337-341
7. Gann PH, Hennekens CH, Ma J, Longcope C and Stampfer MJA (1996) A prospective study of sex hormone levels and risk of prostate cancer. J Natl Cancer Inst 88: 1118-1126
8. Giovannucci E (1995) Epidemiologieal characteristics of prostate cancer. Cancer 75; 1766-1777
9. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA and Willet WC (1997) Height, body weight and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 6: 557-563
10. Gluckman PD, Johnson-Barret TJ, Butler J, Edgar BW and Gunn TR (1983) Studies of insulin-like growth factors-I and -II by specific radioligand assays in umbilical cord blood. Clin Endocrinol 19: 405-413
11. Goodman-Gruen D and Barrett-Connor E (1997) Epidemiology of insulin-like growth factor-1 in men and women. Am J Epidemiol 145: 970-976
12. Hebert PR, Ajani U, Cook NR, Lee I, Chan KS and Hennekens CH (1997) Adult height and incidence of cancer in male physicians (United States). Cancer Causes Control 8; 591-597
13. Johnston R (1983) A Revision of Socio-economic Indices for New Zealand. New Zealand Council for Educational Research: Wellington
14. Juul A, Dalgaard P, Blum WF, Bang P, Hall K and Michaelson KF (1995) Serum levels of insulin-like growth factor (IGF)-binding protein-1 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-1, IGF-II, IGFBP-2, age, sex, body mass index, and pubertal maturation. J Clin Endocrinol Metab 80: 2534-2542
15. Keenam BS, Richards GE, Ponder SW, Dakkas JS, Nagamani M and Smith ER (1993) Androgen-slimulated pubertal growth: the effects of testosterone and dihydrotestosterone on growth hormone and insulin-like growth factor-1 in the treatment of short stature and delayed puberty. J Clin Endocrinol Metab 76: 996-1001
16. Le Marchand L, Kolonel LN, Wilkins LR, Myers BC and Hirohata T (1994) Animal fat consumption and prostate cancer: a prospective study in Hawaii. Epidemiology 5: 276-282
17. Mantzoros CS, Tzonou A, Signorello LB, Tricopoulos D and Adami H-O (1997) Insulin-like growth factor-1 in relation to prostate cancer and benign prostatic hyperplasia. Br 3 Cancer 76: 1115-1118
18. Millar WJ (1986) Distribution of body weight and height: comparison of estimates based upon self-reported and observed measures. J Epidemiol Comm Hlth 40: 319-323
19. Palta M, Princas RJ, Berman R and Hannan P (1982) Comparison of self-reported and measured height and weight. Am J Epidemiol 115: 223-230
20. Rajah R, Valentinis B and Cohen P (1997) Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta 1 on programmed cell death through a p53-and IGF-independent mechanism. J Biol Chem 272: 12181-12188
21. Smith JR, Freije D, Carpten JD, Gronberg H, Xu J, Isaacs SD, et al (1996) A genome-wide search reveals a major susceptibility locus for prostate cancer on chromosome 1. Science 274: 1371-1373
22. Stewart AW, Jackson RT, Ford MA and Beaglehole R (1987) Underestimation of relative weight by use of self-reported height and weight. Am J Epidemiol 125: 122-126
23. Tiblin G, Eriksoon S, Cnattingius S and Ekbom A (1995) High birthweight as a predictor of prostate cancer risk. Epidemiology 6: 423-424
24. Xu J, Myers D, Freije D, Isaacs S, Wiley K, Nusskem D, et al (1998) Evidence for a prostate cancer susceptibility locus on the X chromosome. Nat Genet 20: 175-179